Showing results (11-20 of 21) with videos related to
Sort By:
Pageof 3
Bulletin of Mathematical Biology|March 27, 2021
Patient-Specific Modelling of Blood CoagulationN Ratto, A Bouchnita, P Chelle, et al.British Journal of Haematology|January 1, 1997
Evolution of blood coagulation and fibrinolysis parameters after abrupt versus gradual withdrawal of acenocoumarol in patients with venous thromboembolism: a double-blind randomized studyB Tardy, B Tardy-Poncet, S Laporte-Simitsidis, et al.Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|December 1, 1994
Fibrinolysis and elastic compression: no fibrinolytic effect of elastic compression in healthy volunteersP Conchonnet, P Mismetti, J Reynaud, et al.Fundamental & Clinical Pharmacology|November 18, 1998
Pharmacokinetic and pharmacodynamic variations of acenocoumarol orally administrated either once or twice daily in patients with deep venous thrombosisP Mismetti, J Reynaud, S Laporte-Simitsidis, et al.Journal of Thrombosis and Haemostasis : JTH|June 25, 2009
Thrombin generation and heparin-induced thrombocytopeniaB Tardy-Poncet, M Piot, C Chapelle, et al.Journal of Thrombosis and Haemostasis : JTH|July 23, 2003
Poor anticoagulant response to tissue factor pathway inhibitor in patients with venous thrombosisB Tardy-Poncet, B Tardy, S Laporte, et al.Haemophilia : the Official Journal of the World Federation of Hemophilia|June 30, 2018
Prediction of individual factor VIII or IX level for the correction of thrombin generation in haemophilic patientsP Chelle, A Montmartin, M Piot, et al.Thrombosis Research|July 15, 1996
Effects of long travels in sitting position in elderly volunteers on biological markers of coagulation activation and fibrinolysisB Tardy, B Tardy-Poncet, L Bara, et al.Therapie|November 1, 1992
[Chronopharmacology of fractionated heparin (nadroparin) administrated by subcutaneous route at prophylactic doses in healthy volunteers]P Mismetti, B Perpoint, S Laporte-Simitsidis, et al.Presse Medicale (Paris, France : 1983)|May 4, 1996
[Thrombopenia induced by heparin: treatment with Org 10172. Tolerability and efficacy]B Tardy-Poncet, J Reynaud, B Tardy, et al.Pageof 3